Gene · 1215
Papers3,945
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,945
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High Renal Mast Cell Density Is Associated with Poor Prognosis in Patients with Immunoglobulin A Nephropathy. | Am J Nephrol | 2023 | 37245508 | PubTator, text mining | PubMed |
| Mice as an Animal Model for Japanese Encephalitis Virus Research: Mouse Susceptibility, Infection Route, and Viral Pathogenesis. | Pathogens | 2023 | 37242385 | PubTator, text mining | PubMed |
| Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Comorbidities: Linked by Vascular Pathomechanisms and Vasoactive Mediators? | Medicina (Kaunas) | 2023 | 37241210 | PubTator, text mining | PubMed |
| Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways. | Int J Mol Sci | 2023 | 37239974 | PubTator, text mining | PubMed |
| Role of Complement in the Onset of Age-Related Macular Degeneration. | Biomolecules | 2023 | 37238702 | PubTator, text mining | PubMed |
| A retrospective study on immunohistochemical evaluation of CD34 in the pathogenesis of oral lichen planus. | J Oral Maxillofac Pathol | 2023 | 37234336 | PubTator, text mining | PubMed |
| Identification and quantification of degradome components in human synovial fluid reveals an increased proteolytic activity in knee osteoarthritis patients vs controls. | Proteomics | 2023 | 37226369 | PubTator, text mining | PubMed |
| Identification and validation of CCL2 as a potential biomarker relevant to mast cell infiltration in the testicular immune microenvironment of spermatogenic dysfunction. | Cell Biosci | 2023 | 37221631 | PubTator, text mining | PubMed |
| Attack the ATAK; A Challenging Contemporary Complex: Pathophysiologic, Therapeutic, and Preventive Considerations | Balkan Med J | 2023 | 37218727 | PubTator, text mining | PubMed |
| Vernal Keratoconjunctivitis among Patients Presenting to the Outpatient Department of Ophthalmology of a Tertiary Care Centre: A Descriptive Cross-sectional Study. | JNMA J Nepal Med Assoc | 2023 | 37203921 | PubTator, text mining | PubMed |
| The C-terminal 32-mer fragment of hemoglobin alpha is an amyloidogenic peptide with antimicrobial properties. | Cell Mol Life Sci | 2023 | 37198527 | PubTator, text mining | PubMed |
| Modulating the tumor microenvironment improves antitumor effect of anti-PD-L1 mAb in breast cancer. | Bioimpacts | 2023 | 37193073 | PubTator, text mining | PubMed |
| Myocardial Recovery. | Diagnostics (Basel) | 2023 | 37189604 | PubTator, text mining | PubMed |
| Infliximab Inhibits Colitis Associated Cancer in Model Mice by Downregulating Genes Associated with Mast Cells and Decreasing Their Accumulation. | Curr Issues Mol Biol | 2023 | 37185713 | PubTator, text mining | PubMed |
| Massive platelet-rich thrombus formation in small pulmonary vessels in amniotic fluid embolism: An autopsy study. | BJOG | 2023 | 37184040 | PubTator, text mining | PubMed |
| High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2023 | 37181037 | PubTator, text mining | PubMed |
| Neuro-Immuno-Psychological Aspects of Chronic Urticaria. | J Clin Med | 2023 | 37176575 | PubTator, text mining | PubMed |
| Increased Chymase-Positive Mast Cells in High-Grade Mucoepidermoid Carcinoma of the Parotid Gland. | Int J Mol Sci | 2023 | 37175975 | PubTator, text mining | PubMed |
| Multi-Omics Research Strategies for Psoriasis and Atopic Dermatitis. | Int J Mol Sci | 2023 | 37175722 | PubTator, text mining | PubMed |
| Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes. | Int J Mol Sci | 2023 | 37175617 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1215/papers?page=16